M1 Kliniken AG (FRA:M12)

Market Cap	340.67M +31.3%
Revenue (ttm)	364.30M +7.4%
Net Income	22.13M +38.2%
EPS	1.19 +38.2%
Shares Out	n/a
PE Ratio	15.39
Forward PE	n/a
Dividend	1.20 (6.67%)
Ex-Dividend Date	Jul 9, 2026

Volume	n/a
Open	18.16
Previous Close	18.04
Day's Range	18.16 - 18.16
52-Week Range	12.88 - 19.58
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 8, 2026

About M1 Kliniken AG

M1 Kliniken AG, together with its subsidiaries, provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, Croatia, Hungary, Bulgaria, and Romania. It operates through Beauty and Trade segments. The Beauty segment provides aesthetic surgery services, such as breast augmentation, eyelid lifts, and liposuction; and other aesthetic medical treatment services, including injections with hyaluronic acid and botulinum toxin. This segment also manages a private clinic for plastic and aesthetic surgery; a...

• Industry: Hospitals
• Founded: 2007
• Employees: 280
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: M12

Financial Performance

In 2025, M1 Kliniken AG's revenue was 364.30 million, an increase of 7.40% compared to the previous year's 339.18 million. Earnings were 22.13 million, an increase of 38.17%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 27, 2026

Data Sources Report a data error